Gastroesophageal Reflux Testing

Gastroesophageal reflux disease is a common condition. We all know someone who suffers from classical reflux symptoms such as burping, heartburn or regurgitation. Sometimes, the symptoms can be much less obvious, and may be causing further health issues.

Silent reflux affects approximately 40 to 50% of patients who have GORD.  It is referred to as ‘silent reflux’ because it does not present with the classical symptoms of reflux. Symptoms of silent reflux range from chronic cough, recurrent sore throats, loss of voice, persistent throat clearing, chest pain, choking, wheezing and shortness of breath.

Contamination of reflux throughout the head and neck can be the cause of ear and sinusitis infections, sore throat and a difficulty in swallowing. Reflux can also irritate the airways and be aspirated into the lungs causing chronic cough, breathing difficulties, recurring chest infections, bronchitis or pneumonia.

Our patented & exclusive Gastroesophageal Reflux Test accurately detects the presence and determines the extent and severity of gastroesophageal reflux disease.

The first of it’s kind, this non-invasive nuclear medicine imaging technique precisely identifies contamination of reflux fluid throughout the maxillary sinuses, throat, middle ears, laryngopharynx, airways and lungs.

 

Could silent reflux be causing your chronic, unexplained cough, constant throat clearing or chest or ear infections that continue to re-occur and do not respond to antibiotics?

We can find out with a simple, non-invasive, bulk billed* test.

*Must have a valid Medicare card

What is a Gastroesophageal Reflux Test?

Test Process

 

This simple test is performed in two stages over a 3 hour period. You’ll walk in and walk out of your appointment, with no anesthetic involved and no recovery period. During stage one and two you are free to leave the clinic.

Stage One

Upon arrival to clinic, the Nuclear Medicine technician gives the patient 20ml of an over the counter liquid anti-acid (GastroGel, Gaviscon, or equivilent) followed by 50mL of water with a small dose of Technetium, and another 50mL of water to flush and clear the mouth of the tracer. Dynamic images are taken from the mouth to the stomach in the upright and supine position with the gamma camera.

These images are analysed with special software to detect the presence and indicate the frequency and amplitude of reflux for the upper oesophagus and pharynx/laryngopharynx.

Stage Two

Following a 90-minute break, a study of the head, neck and chest will be performed to detect any aspiration of refluxate into the head and neck structures (including the laryngopharynx) and lungs.

Test Indications

 
  • Chronic cough

  • Chest pain

  • Throat clearing

  • Difficulty swallowing

  • Sinusitis

  • Recurrent chest, throat and/or ear infections

  • Recurrent pneumonia and/or bronchitis

  • New or worsening asthma

  • Breathing disorders or difficulties, such as apnea, or pauses in breathing

  • Atypical symptoms for which an alternate explanation cannot be found

Please Note: This test is not advocated for simple reflux which presents with heartburn and regurgitation as this can be managed clinically without the need for diagnostic testing.

Your Questions Answered…

  • Gastro-oesophageal reflux disease, or GORD, is a digestive disease characterised by chronic acid reflux, which occurs when stomach acid flows back into the oesophagus.

    GORD is caused by a weakening in the esophageal sphincter, which allows stomach acid to flow back up into your esophagus. This constant flow of stomach acid irritates the lining of the esophagus, causing inflammation and discomfort.

    When diagnosis and treatment are delayed, chronic GORD can increase your risk for serious health complications. The thin tissue that lines your esophagus is sensitive, and stomach acid is irritating. It can burn and damage the tissue inside your esophagus, throat, and voice box. For adults, the most common complications of reflux include long-term irritation, tissue scarring, ulcers, and increased risk for certain cancers.

  • Silent reflux is quite common and affects approximately 40 to 50% of patients who have gastroesophageal reflux disease.

    It is referred to as ‘silent reflux’ because it does not present with the classical symptoms of reflux, being heartburn, lump in the throat and regurgitation. There is in fact nothing silent about the symptomatology which is often called atypical.

    These symptoms range from chronic cough, recurrent sore throats, loss of voice, persistent throat clearing, chest pain, choking, wheezing and shortness of breath. We frequently see patients with a diagnosis of “atypical asthma”, which often turns out to be gastro-oesophageal reflux with entry of reflux into the airways.

  • Visit our Available Locations page for more information

  • The Gastroesophageal Reflux Test is BULK BILLED for Medicare card holders.

  • Yes. A referral from your GP or Specialist is required.

  • You are required to fast for 4 hours prior to your examination. Please do not have anything to eat, drink, smoke or chew during the fasting period. All medications (including prescribed reflux medication) must be taken on the day of your examination prior to commencing the 4 hour fasting period.

  • Prior to the introduction of the Gastroesophageal Reflux Test GORD has been diagnosed using pH monitoring, fluoroscopy or endoscopy.

    pH monitoring is performed off therapy. Standard test preparation is to cease anti-reflux therapy for the 3 days prior to the test. This causes a rebound acid effect, and the stomach produces more acid. Although this test is 50-80% sensitive & 77–100% specific in the presence of heartburn & regurgitation, it is limited to oesophageal disease only, particularly the lower oesophagus. This test is expensive, invasive, and may be poorly tolerated by patients.

    Endoscopy is effective as an anatomical diagnostic tool, but has a poor sensitivity for GORD (less than 30%) and is limited to detecting reflux disease that is severe enough to damage the oesophagus.

    Fluoroscopy or Barium Swallow is insensitive and has a high radiation burden and only demonstrates oesophageal disease.

    Gastroesophageal Reflux Testing provides an effective, bulk billed, non-invasive screening tool for oesophageal disease, LPR and lung aspiration, detecting contamination throughout the maxillary sinuses, throat, middle ears, laryngopharynx, airways and lungs. Scintigraphy is 90% sensitive, detecting both acid and non-acid reflux and is well-tolerated by patients.

  • Your treatment options will depend on what the scan and any other relevant investigations reveal.

    Your clinical symptoms and response to treatment as always must be considered.

    Once this information is known a more customised management and treatment plan can be devised and implemented by your GP or specialist. There are a range of lifestyle, medication and surgical options. Ranging from diet modification and timing of meals to a combination of PPIs, antacids, nasal sprays or lung antibiotics.

    If all these options fail, surgery is normally the next step and most appropriate treatment.

“Many patients do not present with classic symptoms of Gastroesophageal Reflux Disease but are suffering from typical upper respiratory tract symptoms such as chronic cough, dysphonia and globus. This is due to reflux fluid contaminating the maxillary sinuses, throat, middle ears and laryngopharynx. It may also contaminate the airways and lungs causing asthma-like symptoms, chronic cough and recurrent bronchitis or pneumonia.”

— Professor Hans Van der Wall

Professor Hans Van der Wall

PhD, FRACP |

Nuclear Medicine Physician

Professor Van der Wall is Professor of Medicine at Notre Dame University in Sydney. He trained at the Prince of Wales Adult and Children's Hospitals and has been a Nuclear Medicine specialist for over 30 years. On completion of his PhD at the University of NSW he took up the position of Director of Nuclear Medicine at Concord Hospital. He is now in full-time private practice.

Dr Van der Wall has supervised 9 PhD students and published over 150 scientific papers in refereed literature. He has co-authored chapters in 8 textbooks of Nuclear Medicine and is a section Editor of the Musculoskeletal Section of the current reference text of Nuclear Medicine (Ell & Gambhir). Dr Van der Wall has been the invited speaker at over 70 international and local meetings including the Society of Nuclear Medicine annual meetings in the US and Europe, World Congress on Low Back Pain and the European Thoracic Society Meeting.

Main research interests are in gastroesophageal reflux testing and the diagnosis of lateralising lower back pain. He has developed and patented tests in both areas and is now offering the Gastroesophageal Reflux Test at four clinic locations across Australia. The research has been validated against the accepted reference standards in both areas.